Mark Grose
Impact in
Papers in
- Co-authors
- Errol B. Marliss (8 shared papers)Darren R. Shafren (22 shared papers)Brendan D. Curti (12 shared papers)Sigrun Hallmeyer (9 shared papers)Thomas A. Seemayer (3 shared papers)Jean‐François Yale (3 shared papers)J.‐F. Yale (2 shared papers)Mark B. Faries (6 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Diabetes (6 papers)Cancer Research (6 papers)Annals of Oncology (5 papers)Journal for ImmunoTherapy of Cancer (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark Grose
37 papers receiving 519 citations
Peers
Comparison fields: 5 of 71
- Oncology 286
- Genetics 284
- Transplantation 24
- Immunology 144
- Biotechnology 36
Countries citing papers authored by Mark Grose
This map shows the geographic impact of Mark Grose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Grose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Grose more than expected).
Fields of papers citing papers by Mark Grose
This network shows the impact of papers produced by Mark Grose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Grose. The network helps show where Mark Grose may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Grose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 97 | |
| 2 | 1985 | 59 | |
| 3 | 2015 | 54 | |
| 4 | 2017 | 30 | |
| 5 | 1985 | 28 | |
| 6 | 2015 | 27 | |
| 7 | 2017 | 23 | |
| 8 | 1987 | 23 | |
| 9 | 2017 | 23 | |
| 10 | 1984 | 18 | |
| 11 | 2022 | 18 | |
| 12 | 2018 | 15 | |
| 13 | 1987 | 14 | |
| 14 | 2016 | 12 | |
| 15 | 2017 | 11 | |
| 16 | 1988 | 8 | |
| 17 | 2017 | 8 | |
| 18 | 2016 | 7 | |
| 19 | 2015 | 7 | |
| 20 | 1988 | 7 |
About Mark Grose
Mark Grose is a scholar working on Genetics, Oncology, Biotechnology, Surgery and Epidemiology, having authored 37 papers that have together received 549 indexed citations. Recurring topics across this work include Virus-based gene therapy research (23 papers), CAR-T cell therapy research (17 papers), Cancer Research and Treatments (15 papers), Pancreatic function and diabetes (7 papers), Diabetes and associated disorders (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Oncology (286 citations), Genetics (284 citations), Transplantation (24 citations), Immunology (144 citations) and Biotechnology (36 citations). Mark Grose has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Errol B. Marliss, Darren R. Shafren, Brendan D. Curti, Sigrun Hallmeyer, Thomas A. Seemayer, Jean‐François Yale, J.‐F. Yale, Mark B. Faries, Jon Richards and Kevin J. Harrington. Their work appears in journals such as Journal of Clinical Oncology, Diabetes, Cancer Research, Annals of Oncology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.